These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7295878)

  • 1. Pharmacokinetics of cefoxitin administered intramuscularly to rabbits with experimentally-induced renal impairment.
    Garcia MJ; Dominguez-Gil AA; Cepeda M; Dominguez-Gil A
    Biopharm Drug Dispos; 1981; 2(3):205-13. PubMed ID: 7295878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefamandole in rabbits with experimentally induced renal impairment.
    Campillo JA; Dominguez-Gil AA; Cepeda M; Dominguez-Gil A
    J Antibiot (Tokyo); 1980 Mar; 33(3):322-7. PubMed ID: 7380743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefoxitin in patients with normal or impaired renal function.
    Garcia MJ; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
    Eur J Clin Pharmacol; 1979 Sep; 16(2):119-24. PubMed ID: 499308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of experimentally induced renal impairment on the pharmacokinetics of cefadroxil in rabbits.
    Mariño EL; Dominguez-Gil AA; Cepeda M; Otero MJ; Dominguez-Gil A
    Arzneimittelforschung; 1981; 31(3):478-81. PubMed ID: 7194673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of acute renal impairment in the penetration of cefoxitin into interstitial tissue fluid in rabbits.
    Dominguez-Gil AA; Garcia MJ; Cepeda M; Lanao JM; Dominguez-Gil A
    Clin Ther; 1981; 3(6):413-24. PubMed ID: 7260987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of cefadroxil administered orally to rabbits with experimentally induced renal impairment.
    Mariño EL; Pajares M; Dominguez-Gil AA; Cepeda M; Dominguez-Gil A
    Arzneimittelforschung; 1981; 31(9):1459-61. PubMed ID: 7197955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of cefoxitin in the elderly.
    Garcia MJ; Garcia A; Nieto MJ; Dominguez-Gil A; Alonso G; Mellado L
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):503-9. PubMed ID: 7203727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefoxitin pharmacokinetics: relation to three different renal clearance studies in patients with various degrees of renal insufficiency.
    Kampf D; Schurig R; Korsukewitz I; Brückner O
    Antimicrob Agents Chemother; 1981 Dec; 20(6):741-6. PubMed ID: 7325641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleural fluid levels of cefoxitin in patients with renal impairment.
    Barrueco M; Otero MJ; Garcia MJ; Lanao JM; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):485-9. PubMed ID: 3781682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
    Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of cefoxitin in patients with pleural effusion.
    Barrueco M; Garcia MJ; Otero MJ; Dominguez-Gil A; de Letona JM
    Clin Ther; 1981; 3(6):425-35. PubMed ID: 7260988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Molina HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):271-5. PubMed ID: 7107075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefoxitin in normal subjects and in patients with renal insufficiency.
    Humbert G; Fillastre JP; Leroy A; Godin M; Van Winzum C
    Rev Infect Dis; 1979; 1(1):118-26. PubMed ID: 318213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lidocaine on the absorption, disposition and tolerance of intramuscularly administered cefoxitin.
    Sonneville PF; Albert KS; Skeggs H; Gentner H; Kwan KC; Martin CM
    Eur J Clin Pharmacol; 1977 Dec; 12(4):273-9. PubMed ID: 590313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of cefoxitin in patients with ascites.
    Garcia MJ; Dominguez-Gil A; Perez FD; Rodriguez FP; Moronta FD
    Eur J Clin Pharmacol; 1981; 20(5):371-4. PubMed ID: 7286047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of orally administered probenecid on the pharmacokinetics of cefoxitin.
    Vlasses PH; Holbrook AM; Schrogie JJ; Rogers JD; Ferguson RK; Abrams WB
    Antimicrob Agents Chemother; 1980 May; 17(5):847-55. PubMed ID: 7396472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefoxitin administered by i.v. infusion to patients with a pleural effusion.
    Otero MJ; Garcia MJ; Barrueco M; Dominguez-Gil A; Gomez F; Portugal Alvarez J
    Eur J Clin Pharmacol; 1984; 26(3):389-92. PubMed ID: 6734700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefoxitin serum and uterine concentrations following a two-gram intramuscular dose.
    Hemsell DL; Birkett I; Reveley L; Bland JA
    Obstet Gynecol; 1982 Feb; 59(2):149-52. PubMed ID: 7078858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of amikacin in children with normal and impaired renal function.
    Lanao JM; Dominguez-Gil AA; Dominguez-Gil A; Málaga S; Crespo M; Santos F
    Kidney Int; 1981 Jul; 20(1):115-21. PubMed ID: 7300106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic study of a new semisynthetic cephalosporin (AL-226) in rabbits.
    Dominguez-Gil AA; Cepeda M; Vila JL; Garcia JJ
    J Antibiot (Tokyo); 1979 May; 32(5):482-7. PubMed ID: 528394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.